CD8+ T cells are not necessary for 1α,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice

In addition to its role in calcium and phosphorous homeostasis, 1α,25-dihydroxyvitamin D3 [1,25-(OH)2D3] appears to be a modulator of the immune system. Administration of 1,25-(OH)2D3 prevents disease in several autoimmune animal models, including experimental autoimmune encephalomyelitis (EAE). The vitamin D receptor is believed to mediate this activity. Among cells of the immune system, CD8+ T cells have the highest levels of the vitamin D receptor. Because CD8+ T cells have been implicated as both suppressors and effectors of the inflammation associated with multiple sclerosis and EAE, we examined the question of whether the 1,25-(OH)2D3 suppression of EAE occurs through a CD8+ T cell-dependent mechanism. To test this hypothesis, mice that are homozygous knockouts for the α chain of the CD8 receptor and have been characterized as lacking functional CD8+ T cells (CD8+ −/−) were provided 1,25-(OH)2D3 in their diet before EAE induction. Although CD8+ −/− mice fed the same diet lacking 1,25-(OH)2D3 have a high incidence of EAE, EAE did not occur in CD8+ −/− mice fed the diet containing 1,25-(OH)2D3. We conclude that CD8+ T cells neither are needed nor do they play a role in the prevention of EAE by 1,25-(OH)2D3.

[1]  H. DeLuca,et al.  Vitamin D: its role and uses in immunology 1 , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  J. Goverman,et al.  A Pathogenic Role for Myelin-Specific Cd8+ T Cells in a Model for Multiple Sclerosis , 2001, The Journal of experimental medicine.

[3]  J. Goverman,et al.  Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D3 prevention of experimental autoimmune encephalomyelitis , 2001, Journal of Neuroimmunology.

[4]  H. Wekerle,et al.  Myelin Antigen-Specific CD8+ T Cells Are Encephalitogenic and Produce Severe Disease in C57BL/6 Mice1 , 2001, The Journal of Immunology.

[5]  L. Chess,et al.  CD8+ T cells control the TH phenotype of MBP-reactive CD4+ T cells in EAE mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[6]  A. Dick,et al.  Analysis of the cellular infiltrate in the iris during experimental autoimmune encephalomyelitis. , 2000, Investigative ophthalmology & visual science.

[7]  Hans Lassmann,et al.  Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction , 2000, The Journal of experimental medicine.

[8]  Mustafa Dosemeci,et al.  Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates , 2000, Occupational and environmental medicine.

[9]  H. DeLuca,et al.  In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D(3). , 2000, Archives of biochemistry and biophysics.

[10]  R. Kumar,et al.  Potent inhibition of dendritic cell differentiation and maturation by vitamin D analogs. , 2000, Biochemical and biophysical research communications.

[11]  E. Kahana.  Epidemiologic studies of multiple sclerosis: a review. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[12]  H. DeLuca,et al.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. , 2000, Archives of biochemistry and biophysics.

[13]  G. Martino,et al.  Inhibition of Th1 development and treatment of chronic‐relapsing experimental allergic encephalomyelitis by a non‐hypercalcemic analogue of 1,25‐dihydroxyvitamin D3 , 2000, European journal of immunology.

[14]  F. Nashold,et al.  1,25-Dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis , 2000, Journal of Neuroimmunology.

[15]  H. DeLuca,et al.  Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice. , 1999, The Journal of nutrition.

[16]  P. Pietschmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Regulatory Effects of 1�,25-Dihydroxyvitamin D 3 on the Cytokine Production of Human Peripheral Blood Lymphocytes* , 2022 .

[17]  P. Gallien,et al.  Sensory-motor and genito-sphincter dysfunctions in multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  S. Patten,et al.  Symptomatic therapies of multiple sclerosis. , 1999, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  H. DeLuca,et al.  1,25-dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. , 1998, Journal of immunology.

[20]  A. Sette,et al.  Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. , 1997, Journal of immunology.

[21]  H. DeLuca,et al.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Herkel,et al.  Lack of requirement for CD8+ cells in recovery from and resistance to experimental autoimmune encephalomyelitis. , 1995, Journal of autoimmunity.

[23]  H. Spiegelberg,et al.  Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. , 1995, The Journal of nutrition.

[24]  R. Horst,et al.  In vitro modulation of proliferation and phenotype of resting and mitogen-stimulated bovine mononuclear leukocytes by 1,25-dihydroxyvitamin D3. , 1993, Veterinary immunology and immunopathology.

[25]  E. Ritz,et al.  1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. , 1993, Blood.

[26]  T. Mak,et al.  Less Mortality but More Relapses in Experimental Allergic Encephalomyelitis in CD8-/- Mice , 1992, Science.

[27]  Hong Jiang,et al.  Role of CD8+ T Cells in Murine Experimental Allergic Encephalomyelitis , 1992, Science.

[28]  F. Mokhtarian,et al.  Characterization of a T suppressor cell line that downgrades experimental allergic encephalomyelitis in mice. , 1991, Cellular immunology.

[29]  T. Mak,et al.  CD8 is needed for development of cytotoxic T but not helper T cells , 1991, Cell.

[30]  J. Lemire,et al.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. , 1991, The Journal of clinical investigation.

[31]  J. Mcleod,et al.  Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? , 1990, Journal of neurology, neurosurgery, and psychiatry.

[32]  J. Ceuppens,et al.  T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol. , 1989, Cellular immunology.

[33]  J. Adams,et al.  1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells. , 1989, Molecular immunology.

[34]  S. Manolagas,et al.  1α,25-Dihydroxyvitamin D3 Receptor Distribution and Effects in Subpopulations of Normal Human T Lymphocytes* , 1989 .

[35]  J. Sedgwick.  Long‐term depletion of cd8+ t cells in vivo in the rat: no observed role for cd8+ (cytotoxic/suppressor) cells in the immunoregulation of experimental allergic encephalomyelitis , 1988, European journal of immunology.

[36]  J. Rothbard,et al.  T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. , 1987, Journal of immunology.

[37]  A. Tobler,et al.  1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[38]  S. Manolagas,et al.  1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. , 1984, Science.

[39]  M. Alter,et al.  Distribution of multiple sclerosis. , 1973, Lancet.

[40]  R. Peto,et al.  Smoking and cancer. , 1973, Lancet.

[41]  K. Westlund.  DISTRIBUTION AND MORTALITY TIME TREND OF MULTIPLE SCLEROSIS AND SOME OTHER DISEASES IN NORWAY , 1970, Acta neurologica Scandinavica.

[42]  J. Kurtzke.  ON THE FINE STRUCTURE OF THE DISTRIBUTION OF MULTIPLE SCLEROSIS , 1967, Acta neurologica Scandinavica.

[43]  J. Presthus.  REPORT ON THE MULTIPLE SCLEROSIS INVESTIGATIONS IN WEST‐NORWAY , 1960, Acta psychiatrica Scandinavica. Supplementum.

[44]  P. Gregersen,et al.  Oligoclonality of CD8+ T cells in multiple sclerosis. , 1996, Autoimmunity.

[45]  M. Sporn,et al.  Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Ed,et al.  Effect of 1,25-dihydroxyvitamin D3 in vivo on circulating T lymphocytes. , 1989 .

[47]  P. Goldberg.  Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence. (A viewpoint). Part 1. Sunlight, dietary factors and epidemiology. , 1974 .

[48]  R. Martenson,et al.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. , 1972, Preparative biochemistry.